146
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Remote Efficacy for Two Different Forms of Hyaluronate-Based Adhesion Barriers

, MS, , BA, , BS, , MD & , PhD
Pages 174-180 | Received 24 May 2011, Accepted 16 Aug 2011, Published online: 14 May 2012

REFERENCES

  • Menzies D, Ellis H. Intestinal obstruction from adhesions—how big is the problem? Ann R Coll Surg Engl. 1990;72(1):60–63.
  • Menzies D. Peritoneal adhesions: incidence, cause, and prevention. Surg Annu. 1992;24:27–45.
  • Ellis H. The aetiology of post-operative abdominal adhesions; an experimental study. Br J Surg. 1962;50:10–16.
  • van Goor H. Consequences and complications of peritoneal adhesions. Colorectal Dis. 2007;9(Suppl. 2):25–34.
  • Parker MC, Wilson MS, Menzies D, The SCAR-3 study: 5-year adhesion-related readmission risk following lower abdominal surgical procedures. Colorectal Dis. 2005;7(6):551–558.
  • Wilson M. Cost and economics of adhesions. Hosp Med. 2004;65(6):343–347.
  • Ellis H, Crowe A. Medico-legal consequences of post-operative intra-abdominal adhesions. Int J Surg. 2009;7(3):187–191.
  • Ray NF, Denton WG, Thamer M, Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg. 1998;186(1):1–9.
  • Kusunoki M, Ikeuchi H, Yanagi H, Bioresorbable hyaluronate-carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial. Surg Today. 2005;35(11):940–945.
  • Becker JM, Dayton MT, Fazio VW, Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg. 1996;183:297–306.
  • Diamond MP. Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter, clinical study. Fertil Steril. 1996;66:904–910.
  • Beck DE, Cohen Z, Fleshman JW, A prospective, randomized, multicenter, controlled study of the safety of seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon Rectum. 2003;46(10):1310–1319.
  • Chuang YC, Fan CN, Cho FN, A novel technique to apply a Seprafilm (hyaluronate-carboxymethylcellulose) barrier following laparoscopic surgeries. Fertil Steril. 2008;90(5):1959–1963.
  • Khaitan L, Scholz S, Richards WO. Laparoscopic adhesiolysis and placement of Seprafilm: a new technique and novel approach to patients with intractable abdominal pain. J Laparoendosc Adv Surg Tech A. 2002;12(4):241–247.
  • Takeuchi H, Kitade M, Kikuchi I, A novel instrument and technique for using seprafilm hyaluronic acid/carboxymethylcellulose membrane during laparoscopic myomectomy. J Laparoendosc Adv Surg Tech A. 2006;16(5):497–502.
  • Lim R, Morrill JM, Lynch RC, Practical limitations of bioresorbable membranes in the prevention of intra-abdominal adhesions. J Gastrointest Surg. 2009;13(1):35–41.
  • Burns JW, Colt MJ, Burgess LS, Preclinical evaluation of Seprafilm bioresorbable membrane. Eur J Surg. 1997;163(Suppl. 577):40–48.
  • Burns JW, Skinner K, Colt MJ, A hyaluronate based gel for the prevention of postsurgical adhesions: evaluation in two animal species. Fertil Steril. 1996;66(5):814–821.
  • Menzies D, Ellis H. The role of plasminogen activator in adhesion prevention. Surg Gynecol Obstet. 1991;172(5):362-366.
  • Lim R, Morrill JM, Prushik SG, An FDA approved neurokinin-1 receptor antagonist is effective in reducing intraabdominal adhesions when administered intraperitoneally, but not orally. J Gastrointest Surg. 2008;12 (10):1754–1761.
  • Reed KL, Stucchi AF, Becker JM. Pharmacologic inhibition of adhesion formation and peritoneal tissue-type plasminogen activator activity. Semin Reprod Med. 2008;26(4): 331–340.
  • Aarons CB, Cohen PA, Gower A, Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg. 2007;245(2):176–184.
  • Metwally M, Watson A, Lilford R, Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev. 2006;2(2):CD001298.
  • Gago LA, Saed GM, Chauhan S, Seprafilm (modified hyaluronic acid and carboxymethylcellulose) acts as a physical barrier. Fertil Steril. 2003;80(3):612–616.
  • Kamer E, Unalp H, Tarcan E, Effect of hyaluronic acid-carboxymethylcellulose adhesion barrier on wound healing: an experimental study. Wounds. 2008;20(10): 265–272.
  • Medina M, Paddock HN, Connolly RJ, Novel antiadhesion barrier does not prevent anastomotic healing in a rabbit model. J Invest Surg. 1995;8(3): 179–186.
  • Reijnen MMPJ, De Man BM, Hendriks T, Hyaluronic acid-based agents do not affect anastomotic strength in the rat colon, in either the presence or absence of bacterial peritonitis. Br J Surg. 2000;87(9):1222–1228.
  • Yamaner S, Kalayci M, Barbaros U, Does hyaluronic acid-carboxymethylcellulose (HA-CMC) membrane interfere with the healing of intestinal suture lines and abdominal incisions? Surg Innov. 2005;12(1):37–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.